Vertex announces UK approval for CASGEVY™
Congratulations to Vertex for their UK approval for CASGEVY™, a CRISPR/Cas9 gene-edited therapy, for...
read DetailsModality Solutions, a privately-held company that delivers integrated cold chain management solutions for highly regulated industries, has named Andrew Larrigan, Consulting Engineer. In his position, Larrigan works in part at the Modality Solutions’ Advantage Transportation Simulation Laboratory™.
Houston, Tex. July 19, 2016 — Modality Solutions, LLC, a privately-held company that delivers integrated cold chain management solutions for life sciences and food industries, has hired Andrew Larrigan as consulting engineer. In his position with Modality Solutions, Larrigan works with other dedicated project engineers.
As a component of his position, Andrew works in part at the Advantage Transportation Simulation Laboratory™, which provides valuable data on the impact of five environmental hazards (temperature, humidity, pressure, shock and vibration) on the critical-to-quality attributes of products. He helps with writing protocols and reports for a variety of distribution and thermal testing. His main tasks include: conducting transportation simulation testing; designing and/or implementing thermal packaging applications; updating Standard Operating Procedures and Forms; and writing protocols and reports for testing.
Modality Solutions’ key areas of service are: ensure regulatory compliance; deliver cold chain thermal packaging design / qualification and controlled-environment logistics solutions; conduct transport simulation testing; decrease development cycle times for a faster route-to-market; develop transport validation strategies to support global regulatory applications; and manage clinical trial operations’ cold chain.
Prior to joining Modality Solutions, Larrigan worked for Camelot Trucking, a trucking business in Alvada, Ohio. In Operations & Dispatch, he used his organizational and communication skills to coordinate jobs with drivers and logistic companies.
“Andrew’s high levels of organization and teamwork were part of what attracted Modality Solutions to invite Andrew to join the team,” said Modality Solutions Principal and CFO, Daniel J. Littlefield.
Larrigan attended The Ohio State University where he received his degree in Chemical Engineering. While at The Ohio State University, Larrigan immersed himself in the following elective courses: Air Pollution, Experimental Design, Modeling & Simulation, Fuel Cells. It was in these courses that he found his passion for learning and educating about the environment.
About BioConvergence
BioConvergence is a contract service provider to the life sciences industry, offering outsourcing partnerships for formulation development, testing, labeling and kitting, and supply chain services. Headquartered in Bloomington, Indiana, BioConvergence has over 50 employees with many years of valuable experience in the pharmaceutical and biotechnology industries. The unique E-Transparency® System provides transparency and flexibility to clients, while offering superior, quality-driven outsourcing services. For more information, visit www.bioc.us
To learn more about Modality Solutions, visit https://www.modality-solutions.com/
About Modality Solutions, LLC
Founded in 2011 Modality Solutions delivers integrated cold chain management solutions for highly regulated industries. Its Advantage Transportation Simulation Laboratory™ tests the effects of transportation environmental hazards on formulations. Key areas of service are: ensure regulatory compliance; deliver cold chain thermal packaging design / qualification and controlled-environment logistics solutions; conduct transport simulation testing; decrease development cycle times for a faster route-to-market; develop transport validation strategies to support global regulatory applications; and clinical trial operations. Additional information can be found at http://www.modality-solutions.com.
Contact
Susan Almon-Pesch
for Modality Solutions, LLC
Phone: (858) 205-0516
Email: sue@speschialpr.com
Congratulations to Vertex for their UK approval for CASGEVY™, a CRISPR/Cas9 gene-edited therapy, for...
read DetailsCongratulations to Melinta Therapeutics for their FDA Approval of REZZAYO™ for the Treatment of...
read DetailsCongratulations to Iveric Bio for their FDA approval for IZERVAY™️️, a new treatment for...
read Details